Organigram Global (OGI) Cash from Investing Activities (2018 - 2026)
Organigram Global (OGI) reported Cash from Investing Activities of -$6.0 billion for Q1 2026, down 162.24% year-over-year from $9.6 billion in Q1 2025, and down 192277.8% quarter-over-quarter from -$3.1 million in Q4 2025.
Organigram Global (OGI) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Cash from Investing Activities data on file, last reported at -$6.0 billion in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$6.0 billion, down 162.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 billion (down 62.02% YoY), and the FY2025 annual result was -$58.9 million, down 160.11% from the prior year.
- Cash from Investing Activities eased to -$6.0 billion in Q1 2026 per OGI's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $9.6 billion in Q1 2025 and troughed at -$6.0 billion in Q1 2026.
- A 3-year average of $897.2 million and a median of -$23.6 million in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities jumped 92.93% in 2025, then sank 162.24% in 2026.
- A 3-year view of Cash from Investing Activities shows it stood at -$44.1 million in 2024, then jumped by 92.93% to -$3.1 million in 2025, then sank by 192277.8% to -$6.0 billion in 2026.
- Business Quant data shows OGI's Cash from Investing Activities at -$6.0 billion in Q1 2026, -$3.1 million in Q4 2025, and $9.6 billion in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Organigram Global | 714.36 Mn | 656.41 Mn | 11.96 Mn | -5.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.99 Bn |
| Mar 31, 2026 | -5.99 Bn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Mar 31, 2025 | 9.63 Bn |
| Mar 31, 2025 | 9.63 Bn |
| Dec 31, 2024 | -44.06 Mn |
| Dec 31, 2024 | -44.06 Mn |
| May 31, 2021 | -153.91 Mn |
| May 31, 2021 | -153.91 Mn |
| Feb 28, 2021 | 18.37 Mn |
| Feb 28, 2021 | 18.37 Mn |
| Nov 30, 2020 | 15.81 Mn |
| Nov 30, 2020 | 15.81 Mn |
| Aug 31, 2020 | -177.81 Mn |
| Aug 31, 2020 | -177.81 Mn |
| May 31, 2020 | -23.37 Mn |
| May 31, 2020 | -23.37 Mn |
| Feb 29, 2020 | 68,052.00 |
| Feb 29, 2020 | 68,052.00 |